The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
出版年份 2022 全文链接
标题
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
作者
关键词
-
出版物
Nature Communications
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-02-02
DOI
10.1038/s41467-021-27918-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DNA methylation and breast cancer-associated variants
- (2021) Peh Joo Ho et al. BREAST CANCER RESEARCH AND TREATMENT
- Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control
- (2020) Martin Widschwendter et al. Cancers
- Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials
- (2020) Rowan T. Chlebowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progesterone Regulation of Milk Fat Globule Size Is VLDL Dependent
- (2020) Nurit Argov-Argaman et al. Frontiers in Endocrinology
- Cervical cancer
- (2019) Paul A Cohen et al. LANCET
- Comparative validation of breast cancer risk prediction models and projections for future risk stratification
- (2019) Parichoy Pal Choudhury et al. JNCI-Journal of the National Cancer Institute
- Calibration: the Achilles heel of predictive analytics
- (2019) Ben Van Calster et al. BMC Medicine
- Mammography screening: A major issue in medicine
- (2018) Philippe Autier et al. EUROPEAN JOURNAL OF CANCER
- Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
- (2018) Mitchell H Gail et al. JNCI-Journal of the National Cancer Institute
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix
- (2018) Shijie C Zheng et al. Epigenomics
- Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
- (2018) Mitchell H Gail et al. JNCI-Journal of the National Cancer Institute
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- (2018) Nasim Mavaddat et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
- (2017) Srikant Ambatipudi et al. EUROPEAN JOURNAL OF CANCER
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Next-generation genotype imputation service and methods
- (2016) Sayantan Das et al. NATURE GENETICS
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- Menopause accelerates biological aging
- (2016) Morgan E. Levine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
- (2016) Andrew E Teschendorff et al. Nature Communications
- Progesterone receptor modulates ERα action in breast cancer
- (2015) Hisham Mohammed et al. NATURE
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis
- (2015) Karin van Veldhoven et al. Clinical Epigenetics
- A Complex Intervention for Workflow Enhancement at the Swedish Cervical Cytology Biobank
- (2014) Nasrin Perskvist et al. BIOPRESERVATION AND BIOBANKING
- Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer
- (2014) Gianluca Severi et al. BREAST CANCER RESEARCH AND TREATMENT
- A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival
- (2014) Shahzia Anjum et al. Genome Medicine
- The Swedish Cervical Cytology Biobank: Sample Handling and Storage Process
- (2013) Nasrin Perskvist et al. BIOPRESERVATION AND BIOBANKING
- Epigenome-wide Association Study of Breast Cancer Using Prospectively Collected Sister Study Samples
- (2013) Zongli Xu et al. JNCI-Journal of the National Cancer Institute
- The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
- (2013) Martin Widschwendter et al. LANCET ONCOLOGY
- Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
- (2012) K. Brennan et al. CANCER RESEARCH
- Genome-Wide Progesterone Receptor Binding: Cell Type-Specific and Shared Mechanisms in T47D Breast Cancer Cells and Primary Leiomyoma Cells
- (2012) Ping Yin et al. PLoS One
- Risk of Primary Non-Breast Cancer After Female Breast Cancer by Age at Diagnosis
- (2011) L. Mellemkjaer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Breast-Cancer Screening
- (2011) Ellen Warner NEW ENGLAND JOURNAL OF MEDICINE
- Robust relationship inference in genome-wide association studies
- (2010) Ani Manichaikul et al. BIOINFORMATICS
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started